"Fortis Healthcare Singapore Pte Ltd, company's offshore subsidiary, has acquired 85 per cent stake in RadLink-Asia Pte Ltd, an outpatient diagnostic and molecular imaging chain in Singapore, for a purchase consideration of S62.9 million dollar," the domestic healthcare major said in a filing to the BSE.

The Indian firm said this transaction will provide Fortis Healthcare a strong foothold in the premium diagnostics and molecular imaging segment in one of South East Asia's most attractive markets.

Fortis further said the investment will provide a complementary platform to its upcoming specialty hospital on Adam Road in Singapore.

Radlink has four main business segments – diagnostic imaging, molecular imaging, cyclotron (radio isotopes manufacturing) and GP clinics, the filing said.